Candida Spp. in Human Intestinal Health and Disease: More Than a Gut Feeling

Overview

Journal Mycopathologia

Specialties Microbiology
Pharmacology

Date 2023 Jun 9

PMID 37294505

Authors

Irini A M Kreulen

Wouter J de Jonge

Rene M van den Wijngaard

Isabelle A M van Thiel

Affiliations

Soon will be listed here.

Abstract

Fungi are an essential part of the normal collection of intestinal microorganisms, even though their collective abundance comprises only 0.1-1% of all fecal microbes. The composition and role of the fungal population is often studied in relation to early-life microbial colonization and development of the (mucosal) immune system. The genus Candida is frequently described as one of the most abundant genera, and altered fungal compositions (including elevated abundance of Candida spp.) have been linked with intestinal diseases such as inflammatory bowel disease and irritable bowel syndrome. These studies are performed using both culture-dependent and genomic (metabarcoding) techniques. In this review, we aimed to summarize existing data on intestinal Candida spp. colonization in relation to intestinal disease and provide a brief overview of the biological and technical challenges in this field, including the recently described role of sub-species strain variation of intestinal Candida albicans. Together, the evidence for a contributing role of Candida spp. in pediatric and adult intestinal disease is quickly expanding, even though technical and biological challenges may limit full understanding of host-microbe interactions.

Citing Articles

Hyperlipidaemia treatment and gut microbiology.

Zhe L, ChunLi Y Front Microbiol. 2025; 15():1520252.

PMID: 39867495 PMC: 11758981. DOI: 10.3389/fmicb.2024.1520252.

The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections.

Sey E, Warris A Oxf Open Immunol. 2024; 5(1):iqae008.

PMID: 39193472 PMC: 11316619. DOI: 10.1093/oxfimm/iqae008.

Is a Dispensable Gene for Viability but Required for Proper Interaction with the Host.

Hernandez-Chavez M, Martinez-Duncker I, Clavijo-Giraldo D, Lopez-Ramirez L, Mora-Montes H J Fungi (Basel). 2024; 10(7).

PMID: 39057387 PMC: 11277967. DOI: 10.3390/jof10070502.

In vitro analysis of postbiotic antimicrobial activity against Candida Species in a minimal synthetic model simulating the gut mycobiota in obesity.

Garcia-Gamboa R, Perfecto-Avalos Y, Gonzalez-Garcia J, Alvarez-Calderon M, Gutierrez-Vilchis A, Garcia-Gonzalez A Sci Rep. 2024; 14(1):16760.

PMID: 39033245 PMC: 11271299. DOI: 10.1038/s41598-024-66806-3.

References

Sokol H, Leducq V, Aschard H, Pham H, Jegou S, Landman C . Fungal microbiota dysbiosis in IBD. Gut. 2016; 66(6):1039-1048. PMC: 5532459. DOI: 10.1136/gutjnl-2015-310746. View

Dohlman A, Klug J, Mesko M, Gao I, Lipkin S, Shen X . A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022; 185(20):3807-3822.e12. PMC: 9564002. DOI: 10.1016/j.cell.2022.09.015. View

van Tilburg Bernardes E, Pettersen V, Gutierrez M, Laforest-Lapointe I, Jendzjowsky N, Cavin J . Intestinal fungi are causally implicated in microbiome assembly and immune development in mice. Nat Commun. 2020; 11(1):2577. PMC: 7244730. DOI: 10.1038/s41467-020-16431-1. View

Saiman L, Ludington E, Pfaller M, Wiblin R, Dawson J, Blumberg H . Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000; 19(4):319-24. DOI: 10.1097/00006454-200004000-00011. View

Rao C, Coyte K, Bainter W, Geha R, Martin C, Rakoff-Nahoum S . Multi-kingdom ecological drivers of microbiota assembly in preterm infants. Nature. 2021; 591(7851):633-638. PMC: 7990694. DOI: 10.1038/s41586-021-03241-8. View

Schaffer T, Muller S, Flogerzi B, Seibold-Schmid B, Schoepfer A, Seibold F . Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflamm Bowel Dis. 2007; 13(11):1339-46. DOI: 10.1002/ibd.20228. View

Ashton J, Ennis S, Beattie R . Early-onset paediatric inflammatory bowel disease. Lancet Child Adolesc Health. 2018; 1(2):147-158. DOI: 10.1016/S2352-4642(17)30017-2. View

Qin H, Cheng C, Tang X, Bian Z . Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014; 20(39):14126-31. PMC: 4202343. DOI: 10.3748/wjg.v20.i39.14126. View

van Thiel I, Rahman S, Hakvoort T, Davids M, Verseijden C, van Hamersveld P . Fecal Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis. Microorganisms. 2022; 10(4). PMC: 9031408. DOI: 10.3390/microorganisms10040737. View

10.

Lin Y, Lau H, Liu Y, Kang X, Wang Y, Ting N . Altered Mycobiota Signatures and Enriched Pathogenic Aspergillus rambellii Are Associated With Colorectal Cancer Based on Multicohort Fecal Metagenomic Analyses. Gastroenterology. 2022; 163(4):908-921. DOI: 10.1053/j.gastro.2022.06.038. View

11.

Henderickx J, de Weerd H, Groot Jebbink L, van Zoeren-Grobben D, Hemels M, van Lingen R . The first fungi: mode of delivery determines early life fungal colonization in the intestine of preterm infants. Microbiome Res Rep. 2023; 1(1):7. PMC: 10714301. DOI: 10.20517/mrr.2021.03. View

12.

Ventin-Holmberg R, Saqib S, Korpela K, Nikkonen A, Peltola V, Salonen A . The Effect of Antibiotics on the Infant Gut Fungal Microbiota. J Fungi (Basel). 2022; 8(4). PMC: 9032081. DOI: 10.3390/jof8040328. View

13.

McDonough L, Mishra A, Tosini N, Kakade P, Penumutchu S, Liang S . Candida albicans Isolates 529L and CHN1 Exhibit Stable Colonization of the Murine Gastrointestinal Tract. mBio. 2021; 12(6):e0287821. PMC: 8561340. DOI: 10.1128/mBio.02878-21. View

14.

Nash A, Auchtung T, Wong M, Smith D, Gesell J, Ross M . The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome. 2017; 5(1):153. PMC: 5702186. DOI: 10.1186/s40168-017-0373-4. View

15.

Lutgens M, van Oijen M, van der Heijden G, Vleggaar F, Siersema P, Oldenburg B . Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013; 19(4):789-99. DOI: 10.1097/MIB.0b013e31828029c0. View

16.

Lewis J, Chen E, Baldassano R, Otley A, Griffiths A, Lee D . Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. Cell Host Microbe. 2015; 18(4):489-500. PMC: 4633303. DOI: 10.1016/j.chom.2015.09.008. View

17.

Barberio B, Massimi D, Cazzagon N, Zingone F, Ford A, Savarino E . Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology. 2021; 161(6):1865-1877. DOI: 10.1053/j.gastro.2021.08.032. View

18.

Zhang F, Aschenbrenner D, Yoo J, Zuo T . The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly. Lancet Microbe. 2022; 3(12):e969-e983. DOI: 10.1016/S2666-5247(22)00203-8. View

19.

Samara J, Moossavi S, Alshaikh B, Ortega V, Pettersen V, Ferdous T . Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host Microbe. 2022; 30(5):696-711.e5. DOI: 10.1016/j.chom.2022.04.005. View

20.

Pohl J, Ring A, Stremmel W, Stiehl A . The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 2005; 18(1):69-74. DOI: 10.1097/00042737-200601000-00012. View